Transaction DateRecipientSharesTypePriceValue
1st October 2020Steven Girgenti33,333Discretionary transaction$0.21$6,999.93
30th September 2020Lowell Rush33,333Other acquisition or disposition$0.21$6,999.93
30th September 2020Capital Management Ltd Fountainhead535,714Other acquisition or disposition$0.21$112,499.94
1st July 2020Steven Girgenti33,333Discretionary transaction$0.21$6,999.93
30th June 2020Lowell Rush33,333Other acquisition or disposition$0.21$6,999.93
30th June 2020Oscar Bronsther33,333Other acquisition or disposition$0.21$6,999.93
30th June 2020Capital Management Ltd Fountainhead535,714Other acquisition or disposition$0.21$112,499.94
1st April 2020Steven Girgenti33,333Discretionary transaction$0.21$6,999.93
31st March 2020Capital Management Ltd Fountainhead535,714Other acquisition or disposition$0.21$112,499.94
31st March 2020Lowell Rush33,333Other acquisition or disposition$0.21$6,999.93
Vycor Medical
Vycor Medical logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.


Vycor Medical, Inc. engages in the provision of innovative surgical and therapeutic solutions to the medical community. The company operates in two segments: Vycor medical and NovaVision. The NovaVision segment offers neuro stimulation therapies and diagnostic devices.


Ticker: VYCO
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1424768
Employees: 9
Exchange: US OTC
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals